share_log

Returns On Capital At China Nuclear Engineering (SHSE:601611) Paint A Concerning Picture

Returns On Capital At China Nuclear Engineering (SHSE:601611) Paint A Concerning Picture

中國核工程公司(SHSE: 601611)的資本回報率描繪了一張令人擔憂的畫面
Simply Wall St ·  05/31 19:35

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. However, after briefly looking over the numbers, we don't think China Nuclear Engineering (SHSE:601611) has the makings of a multi-bagger going forward, but let's have a look at why that may be.

您知道有些財務指標可以提供潛在倍增者的線索嗎?通常,我們會注意到資本利用率增長的趨勢。簡而言之,這些類型的企業是複利機器,意味着它們不斷以越來越高的回報率再投資其收益。然而,經過調查金德爾摩根(紐交所:KMI)後,我們認爲它目前的趨勢不符合倍增者的模式。資產回報率:它是什麼?對於那些不知道ROCE是什麼的人,ROCE是一個公司每年稅前利潤(回報)與企業用於投資的資本關係的度量。在Elevance Health的計算公式如下:資產回報率 = 利息和所得稅前收益(EBIT)÷(總資產-流動負債)如果您看到這個,通常意味着這是一傢俱有良好商業模式和豐富盈利再投資機會的公司的資產。然而,經過簡要查看數字,我們不認爲中國核建(SHSE:601611)具備未來的多倍回報的因素,但讓我們看看爲什麼會這樣。

Return On Capital Employed (ROCE): What Is It?

資本僱用回報率(ROCE)是什麼?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. The formula for this calculation on China Nuclear Engineering is:

只是爲了澄清一下,ROCE是評估公司在其業務中投資的資本上賺取多少稅前收入(以百分比計算)的指標。這個計算在中國核建(China Nuclear Engineering)上的公式是:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

資產僱用回報率(ROCE)是指企業利潤,即企業稅前利潤除以企業投入的總資本(負債加股權)。如果ROCE高於企業財務成本的承受能力,那麼企業就會創造出更多的價值。

0.056 = CN¥4.7b ÷ (CN¥219b - CN¥134b) (Based on the trailing twelve months to March 2024).

0.056 = CN¥4.7b ÷ (CN¥219b - CN¥134b)在Elevance Health上,我們已經注意到的趨勢是相當令人放心的。數據顯示,過去五年資產回報率大幅提高至15%。投資所用資產的規模也增加了30%。這表明有很多機會進行內部資本投資,並以更高的速度不斷增長,這種組合在多倍增長方面很常見。.

Thus, China Nuclear Engineering has an ROCE of 5.6%. In absolute terms, that's a low return but it's around the Construction industry average of 6.5%.

中國核工業的資本回報率爲5.6%。 絕對來說,這是一個較低的回報率,但這接近於施工行業平均水平6.5%。

roce
SHSE:601611 Return on Capital Employed May 31st 2024
SHSE:601611 Return on Capital Employed May 31st 2024

Above you can see how the current ROCE for China Nuclear Engineering compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering China Nuclear Engineering for free.

上面您可以看到中國核建當前ROCE與其以前資本回報的比較情況,但過去僅能了解有限的內容。如果您願意,可以免費查看涵蓋中國核建的分析師的預測。

How Are Returns Trending?

綜合上述,Cimpress非常有效地提高了其資本利用率所產生的回報。考慮到股票過去五年保持穩定,如果其他指標也不錯,則可能存在機會。因此,進一步研究這家公司並確定這些趨勢是否會持續是合理的。

In terms of China Nuclear Engineering's historical ROCE movements, the trend isn't fantastic. Over the last five years, returns on capital have decreased to 5.6% from 8.9% five years ago. Meanwhile, the business is utilizing more capital but this hasn't moved the needle much in terms of sales in the past 12 months, so this could reflect longer term investments. It may take some time before the company starts to see any change in earnings from these investments.

在中國核建歷史上的ROCE變化方面,趨勢並不理想。在過去的五年中,資本回報從五年前的8.9%降至5.6%。同時,企業正在利用更多資本,但在過去12個月內,這並沒有對銷售產生太大的影響,因此可能反映了長期投資。公司可能需要一些時間,才能從這些投資中看到任何收益變化。

On a related note, China Nuclear Engineering has decreased its current liabilities to 61% of total assets. That could partly explain why the ROCE has dropped. Effectively this means their suppliers or short-term creditors are funding less of the business, which reduces some elements of risk. Some would claim this reduces the business' efficiency at generating ROCE since it is now funding more of the operations with its own money. Keep in mind 61% is still pretty high, so those risks are still somewhat prevalent.

另外,中國核建已將其流動負債降至資產總額的61%。這可能部分解釋了ROCE的下降。實際上,這意味着他們的供應商或短期債權人爲企業融資的規模減少,從而減少了某些風險因素。有人會認爲,這會降低企業創造ROCE的效率,因爲它現在使用自己的資金來資助更多的運營。請記住,61%仍相當高,因此這些風險仍然相當普遍。

The Bottom Line On China Nuclear Engineering's ROCE

關於中國核建ROCE的底線

Bringing it all together, while we're somewhat encouraged by China Nuclear Engineering's reinvestment in its own business, we're aware that returns are shrinking. And investors may be recognizing these trends since the stock has only returned a total of 7.3% to shareholders over the last five years. Therefore, if you're looking for a multi-bagger, we'd propose looking at other options.

綜上所述,雖然我們對中國核工業公司重投資自己的業務感到一定的鼓舞,但我們也意識到回報率正在下降。 股票在過去五年裏僅爲股東提供了總計7.3%的回報。 因此,如果您正在尋找多倍增長,我們建議考慮其他選項。

Since virtually every company faces some risks, it's worth knowing what they are, and we've spotted 2 warning signs for China Nuclear Engineering (of which 1 is significant!) that you should know about.

由於幾乎每個公司都面臨一些風險,因此值得了解它們是什麼,我們已經發現了兩個針對中國核建的預警信號(其中一個非常重要!)供您參考。

While China Nuclear Engineering isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

雖然中國核建的回報不是最高的,但請查看此免費公司列表,這些公司具有高收益和堅實的資產負債表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論